Thompson Investment Management’s Novartis NVS Stock Holding History

Thompson Investment Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.86K	Hold	31	–	–	﹤0.01%	450
2026 Q1	$4.74K	Hold	31	–	–	﹤0.01%	438
2025 Q4	$4.27K	Hold	31	–	–	﹤0.01%	445
2025 Q3	$3.98K	Hold	31	–	–	﹤0.01%	437
2025 Q2	$3.75K	Hold	31	–	–	﹤0.01%	435
2025 Q1	$3.46K	Hold	31	–	–	﹤0.01%	427
2024 Q4	$3.02K	Hold	31	–	–	﹤0.01%	436
2024 Q3	$3.57K	Hold	31	–	–	﹤0.01%	424
2024 Q2	$3.3K	Hold	31	–	–	﹤0.01%	427
2024 Q1	$3K	Hold	31	–	–	﹤0.01%	445
2023 Q4	$3.13K	Hold	31	–	–	﹤0.01%	375
2023 Q3	$3.16K	Hold	31	–	–	﹤0.01%	364
2023 Q2	$3.13K	Hold	31	–	–	﹤0.01%	373
2023 Q1	$2.85K	Buy	+31	New	+$2.71K	﹤0.01%	370

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Thompson Investment Management's NVS Position: Q2 2026 in Review

Thompson Investment Management held its Novartis (NVS) position steady in Q2 2026 at 31 shares worth $4.86K. The position accounts for ﹤0.01% of the portfolio, ranked #450.

Thompson Investment Management first reported a position in NVS in Q1 2023 and has held it in 14 quarters since. 1,611 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Thompson Investment Management held 31 shares of Novartis worth $4.86K as of Q2 2026.
Thompson Investment Management left its Novartis share count unchanged in Q2 2026.
Novartis made up ﹤0.01% of Thompson Investment Management's portfolio in Q2 2026, its #450 holding.
Thompson Investment Management first reported a position in Novartis in Q1 2023 and has held it in 14 quarters since.
1,611 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Thompson Investment Management's 13F filing for Q2 2026, filed 13 Jul 2026.